SequelSEC

GUIDED THERAPEUTICS INC GTHP

Electromedical & Electrotherapeutic Apparatus · CIK 0000924515 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$650.00K
Fiscal year ended 2026-06-30
Operating income
-$1.98M
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$10.52MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$0.11Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue13.7×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Electromedical & Electrotherapeutic Apparatus filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Current ratio0.09x0th
Revenue YoY growth10857.1%100th
SBC / revenue49.2%95th
CapEx / revenue0.3%10th
Operating margin-309.3%14th
Net margin-416.7%15th
R&D / revenue61.1%82th
Gross margin74.4%81th
FCF margin-139.5%20th

GUIDED THERAPEUTICS INC (GTHP) reported revenue of $650.00K and net income of -$3.06M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from GUIDED THERAPEUTICS INC’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Electromedical & Electrotherapeutic Apparatus.

Income

GUIDED THERAPEUTICS INC income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$650.00K
Cost of revenue$157.00K
Gross profit$493.00K
Operating income-$1.98M
Net income-$3.06M
Research & development$342.00K
Weighted-average diluted sharesUnavailable
Pretax income-$3.06M
Income tax expense$0
Diluted EPSUnavailable
Selling, general & administrative$2.34M
General & administrative$2.25M
Selling & marketing$91.00K

Balance

GUIDED THERAPEUTICS INC balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalentsUnavailable
Total assets$1.20M
Current assets$527.00K
Total liabilities$6.96M
Current liabilities$6.17M
Total equity incl. NCI-$5.76M
Temporary (mezzanine) equityUnavailable
Inventory$500.00K
Accounts receivable$4.00K
GoodwillUnavailable
Long-term debt$53.00K
Accounts payable$2.35M

Cash flow

GUIDED THERAPEUTICS INC cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$1.50M
Capital expendituresUnavailable
Investing cash flowUnavailable
Financing cash flow$1.33M
Net change in cashUnavailable
Stock-based compensation$126.00K
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortizationUnavailable

Derived

GUIDED THERAPEUTICS INC derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flowUnavailable
Gross margin75.8%
Operating margin-303.8%
FCF marginUnavailable
SBC / revenue19.4%
Current ratio0.09x
Revenue YoY growth450.8%
Net margin-471.5%
R&D / revenue52.6%
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open GTHP in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-13View SEC filing
10-Q · Filed 2026-05-15View SEC filing
10-K · Filed 2026-03-31View SEC filing
10-Q · Filed 2025-11-13View SEC filing
10-Q · Filed 2025-08-14View SEC filing
10-Q · Filed 2025-05-15View SEC filing

Companies in the same industry

ADMT AXGN BLFS CBLL CNMD CV ECOR ELMD ESMC FOCL HCIL HYPR

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.